UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

Leukemia, 2017-02, Vol.31 (2), p.502-505

2017

Volltextzugriff (PDF)

The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

Cancer chemotherapy and pharmacology, 2022-04, Vol.89 (4), p.551-557

2022

Volltextzugriff (PDF)

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors

Cancer research (Chicago, Ill.), 2004-12, Vol.64 (24), p.9139-9143

2004

Volltextzugriff (PDF)

Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

Clinical cancer research, 2003-08, Vol.9 (9), p.3246-3253

2003

Volltextzugriff (PDF)

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991–2001

JNCI : Journal of the National Cancer Institute, 2002-12, Vol.94 (24), p.1883-1888

2002

Volltextzugriff (PDF)

Pharmacokinetics of 5-Azacitidine Administered With Phenylbutyrate in Patients With Refractory Solid Tumors or Hematologic Malignancies

Journal of clinical oncology, 2005-06, Vol.23 (17), p.3906-3911

2005

Volltextzugriff (PDF)

Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan

Clinical cancer research, 2005-11, Vol.11 (21), p.7800-7806

2005

Volltextzugriff (PDF)

Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy

Molecular cancer therapeutics, 2002-05, Vol.1 (7), p.545

2002

Volltextzugriff (PDF)

Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients

Clinical cancer research, 2004-12, Vol.10 (24), p.8341-8350

2004

Volltextzugriff (PDF)

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Clinical cancer research, 2001-08, Vol.7 (8), p.2292-2300

2001

Volltextzugriff (PDF)

Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly

Journal of clinical oncology, 2005-02, Vol.23 (6), p.1070-1077

2005

Volltextzugriff (PDF)

Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients

Investigational new drugs, 2006-07, Vol.24 (4), p.291-297

2006

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Journal of clinical oncology, 2006-02, Vol.24 (4), p.552-562

2006

Volltextzugriff (PDF)

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Clinical cancer research, 2001-10, Vol.7 (10), p.3229-3238

2001

Volltextzugriff (PDF)

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Clinical cancer research, 2004-03, Vol.10 (6), p.1976-1983

2004

Volltextzugriff (PDF)

Ductal access for prevention and therapy of mammary tumors

Cancer research (Chicago, Ill.), 2006-01, Vol.66 (2), p.638-645

2006

Volltextzugriff (PDF)

Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?

Journal of clinical oncology, 2005-11, Vol.23 (31), p.7765-7767

2005

Volltextzugriff (PDF)

High Telomerase RNA Expression Level Is an Adverse Prognostic Factor for Favorable-Histology Wilms' Tumor

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9138-9145

2005

Volltextzugriff (PDF)

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

Clinical cancer research, 2005-10, Vol.11 (20), p.7398-7404

2005

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

Clinical cancer research, 2005-01, Vol.11 (2), p.664-671

2005

Volltextzugriff (PDF)

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study

Neuro-oncology (Charlottesville, Va.), 2005-04, Vol.7 (2), p.177-182

2005

Volltextzugriff (PDF)

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Cancer chemotherapy and pharmacology, 2003-03, Vol.51 (3), p.231-239

2003

Volltextzugriff (PDF)

Phase I study of Docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with a unique pharmacology and toxicity profile

Clinical cancer research, 2003-09, Vol.9 (10), p.3589-3597

2003

Volltextzugriff (PDF)

Predicting vinorelbine disposition and toxicity: does BSA provide more than a "bad statistical association"?

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2412-2413

2006

Volltextzugriff (PDF)

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Clinical cancer research, 2006-01, Vol.12 (2), p.536-542

2006

Volltextzugriff (PDF)

1 – 25 von 63

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(62)
Tagungsberichte
(1)

Sprache

Englisch
(63)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(63)
Science & Technology
(63)
Humans
(60)
Biological And Medical Sciences
(43)
Medical Sciences
(43)
Female
(42)
Adult
(39)
Male
(39)
Middle Aged
(38)
Antineoplastic Agents
(37)
Pharmacology. Drug Treatments
(37)
Aged
(36)
Chemotherapy
(30)
Neoplasms - Drug Therapy
(28)
Dose-Response Relationship, Drug
(16)
Drug Administration Schedule
(16)
Neoplasms - Metabolism
(15)
Antineoplastic Agents - Pharmacokinetics
(14)
Infusions, Intravenous
(14)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

E3 ubiquitin ligase Cbl-b activates the p53 pathway by targeting Siva1, a negative regulator of ARF, in FLT3 inhibitor-resistant acute myeloid leukemia

The effects of pazopanib on doxorubicin pharmacokinetics in children and adults with non-rhabdomyosarcoma soft tissue sarcoma: a report from Children’s Oncology Group and NRG Oncology study ARST1321

An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors

Irinotecan Pathway Genotype Analysis to Predict Pharmacokinetics

Role of Body Surface Area in Dosing of Investigational Anticancer Agents in Adults, 1991–2001

Pharmacokinetics of 5-Azacitidine Administered With Phenylbutyrate in Patients With Refractory Solid Tumors or Hematologic Malignancies

Effect of Milk Thistle (Silybum marianum) on the Pharmacokinetics of Irinotecan

Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy

Factors Affecting Cytochrome P-450 3A Activity in Cancer Patients

A Phase I Dose Escalation and Bioavailability Study of Oral Sodium Phenylbutyrate in Patients with Refractory Solid Tumor Malignancies

Prospective Evaluation of the Pharmacokinetics and Toxicity Profile of Docetaxel in the Elderly

Binding of gefitinib, an inhibitor of epidermal growth factor receptor-tyrosine kinase, to plasma proteins and blood cells: in vitro and in cancer patients

Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

Tumor Targeting by Covalent Conjugation of a Natural Fatty Acid to Paclitaxel

Comparative Pharmacokinetics of Weekly and Every-Three-Weeks Docetaxel

Ductal access for prevention and therapy of mammary tumors

Paclitaxel repackaged in an albumin-stabilized nanoparticle: handy or just a dandy?

High Telomerase RNA Expression Level Is an Adverse Prognostic Factor for Favorable-Histology Wilms' Tumor

Effect of Common CYP3A4 and CYP3A5 Variants on the Pharmacokinetics of the Cytochrome P450 3A Phenotyping Probe Midazolam in Cancer Patients

A Phase I and Pharmacokinetic Study of Short Infusions of UCN-01 in Patients with Refractory Solid Tumors

Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study

Phase I trial of continuous infusion 5-aza-2'-deoxycytidine

Phase I study of Docosahexaenoic acid-paclitaxel: A taxane-fatty acid conjugate with a unique pharmacology and toxicity profile

Predicting vinorelbine disposition and toxicity: does BSA provide more than a "bad statistical association"?

Two Drug Interaction Studies Evaluating the Pharmacokinetics and Toxicity of Pemetrexed When Coadministered with Aspirin or Ibuprofen in Patients with Advanced Cancer

Aktive Filter

Suchergebnisse filtern